60 Degrees Pharmaceuticals, Inc. beat EPS estimates 0% of the time across 2 reported quarters (0 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.74 | $-0.90 | -21.6% | Miss |
| Q12026 FY2026 | $-0.76 | $-1.28 | -68.4% | Miss |
Back to SXTP overview · SXTP holders · SXTP KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.